pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
GLP-1 receptor · news · pharmadog
← back to GLP-1 receptor
News · GLP-1 receptor
471
stories
Jul 16, 26
Opinion: The growing fang-to-pharmacy pipeline
stat
Jul 15, 26
Eli Lilly invests in Oura to support patients on GLP-1 drugs
endpoints
Jul 15, 26
STAT+: Celcuity’s breast cancer drug approved, its first
stat
Jul 15, 26
STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and more
stat
Jul 15, 26
STAT+: A new biotech startup tries to tackle obesity, but not in the way you might expect
stat
Jul 14, 26
STAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and more
stat
Jul 9, 26
STAT+: OpenEvidence backs study that finds it beats LLMs
stat
Jul 9, 26
Opinion: Who benefits from classifying obesity as a disease?
stat
Jul 9, 26
What happens on ‘MAHA Monday’?
stat
Jul 8, 26
Biohaven looks to take on Lilly in the muscle-sparing obesity space
endpoints
Jul 8, 26
STAT+: Europe will accelerate its review of RevMed’s drug
stat
Jul 7, 26
Kailera says obesity pill succeeds in late-stage trial in China
biopharma dive
Jul 7, 26
Hengrui, Kailera's GLP-1 pill posts encouraging efficacy but high side effect rates in late-stage China trials
endpoints
Jul 7, 26
STAT+: ‘Secret shopper’ study probes GLP-1 telehealth sites
stat
Jul 7, 26
STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and more
stat
Jul 7, 26
Ebola outbreak exposes a fractured outbreak response system
stat
Jul 6, 26
Obamacare rolls shrank dramatically in many states over the past year, new federal data shows
stat
Jul 6, 26
New CDER appointment elevates longtime GLP-1 reviewer
endpoints
Jul 6, 26
STAT+: Online GLP-1 prescriptions are often fast, easy — and low on clinical oversight
stat
Jul 6, 26
Opinion: The smart way to regulate the peptide boom
stat
Jul 6, 26
What does content creation do to mental health?
stat
Jul 2, 26
STAT+: Elevance sues government over $115 million tied to Medicare Advantage star ratings
stat
Jul 2, 26
BrightGene looks to the West as obesity shot nears China approval
endpoints
Jul 1, 26
Statins and blood pressure drugs changing health risks of obesity, study suggests
stat
Jun 30, 26
STAT+: Investors double down on Bain-backed startup
stat
Jun 30, 26
STAT+: The loophole in Trump’s obesity drug deal with Eli Lilly and Novo Nordisk
stat
Jun 29, 26
STAT+: 26 states sue to block Medicaid work requirements
stat
Jun 29, 26
STAT+: Unredacted comments from California hospital lawsuits show stunning admissions and a ‘forced’ McKinsey collaboration
stat
Jun 29, 26
STAT+: Longevity, wellness physicians named to panel advising FDA on peptides
stat
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
← prev
page 13 of 16
next →